Metraipolis › archive › dc_83a75d71e44f

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope — Europe PMC PMID:41090116

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41090116
DOI
10.1093/rap/rkaf104
License (as archived)
solo-consultazione
Archived
2026-11-09T08:06:44.561Z
SHA-256 of the archived text
d843e0e337c88626854ea24ad4cde5b0d4d7487e3c2bec0f011edc5a8c9a9f90
Stable URL of this page
https://metraipolis.com/documento/dc_83a75d71e44f

How to cite

Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope — Europe PMC PMID:41090116 — Europe PMC (en), https://europepmc.org/article/MED/41090116 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_83a75d71e44f (Metraipolis archive dc_83a75d71e44f, sha256 d843e0e337c88626854ea24ad4cde5b0d4d7487e3c2bec0f011edc5a8c9a9f90)
BibTeX
@misc{dc83a75d71e44f,
  title = {Biologic and targeted synthetic DMARD safety in inflammatory arthritis: British Society for Rheumatology guideline scope — Europe PMC PMID:41090116},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41090116},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_83a75d71e44f; sha256 d843e0e337c88626854ea24ad4cde5b0d4d7487e3c2bec0f011edc5a8c9a9f90},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41090116. Agents can read the archived copy with the MCP tool read_document.